Glanbia announces Mary Minnick and Richard Laube to its Board as upcoming Independent Directors

– IRELAND, Kilkenny – Glanbia plc (LON:GLB), the global nutrition group, today announced that Mary Minnick and Richard Laube will join the Board as Independent Non-Executive Directors on 1 May 2019.

To facilitate this reorganisation and the broadening of the external perspective of the Board, Hugh McGuire and Brian Phelan will not be putting themselves forward for re-election at the 2019 Annual General Meeting. Their key executive roles are unaltered and they will continue in their executive leadership positions as CEOs of the Group’s two global growth platforms, Glanbia Performance Nutrition and Glanbia Nutritionals respectively.

Paul Haran, Senior Independent Director, will retire immediately upon completion of the appointment of a third new Independent Non-Executive Director which is expected to be completed during 2019. The Company will announce the appointment of the Independent Board Director to replace Mr Haran and changes to the composition of the Committees (which will continue to comprise only of Independent Non-Executive Directors) in due course.

Following Mr Haran’s retirement, Dan O’Connor will take up the position of Senior Independent Director. The role of Donard Gaynor, an Independent Non-Executive Director, has been expanded to include oversight of workforce engagement to further improve Board involvement in this area.

About Mary Minnick

Mary Minnick was previously a partner of Lion Capital LLP, a consumer-focused private equity firm, from 2007 to 2018. In that role, Ms Minnick was involved in a number of successful investments in well-known retail and consumer branded companies, several of which she chaired. Prior to that, Ms. Minnick had a 23-year career with The Coca-Cola Company, where she held a variety of senior management positions, including Chief Operating Officer of the Asian region, Division President roles in the Japan, South Pacific and Asian regions, and ultimately as the company’s Chief Marketing Officer and Global President of Strategy and Innovation. She is an experienced Board Director and is currently a member of the Boards of Target Corporation and Leo Holdings Corp, both of which are publicly-traded in the US. Previously she was a member of the Boards of Heineken NV and Whitewave Foods, also US publicly traded. Ms Minnick holds an MBA from Duke University in the US and a BS in Business Administration from Bowling Green State University in the US.

About Richard Laube

Richard Laube was CEO of Nobel Biocare, a Swiss listed medical device business, from April 2011 to April 2016. Prior to that Mr. Laube served as Executive Board Member of Nestlé SA, from April 2005 to September 2010, and served operationally as CEO of Nestlé Nutrition. Before Nestlé, Mr. Laube served as Executive Committee member of Roche Holding AG and was operationally responsible for Roche Consumer Health. Earlier in his career he held positions of increasing responsibility in brand and general management at Procter & Gamble, including international assignments in Switzerland, the USA, Japan, Germany and Brazil. Mr. Laube is an experienced company director, having served as Chairman of Atkins Nutritionals Inc. from January 2011 to July 2017 and remained as independent director of the Simply Good Foods Company upon the company’s successful initial public offering on NASDAQ in July 2017. He currently serves as a Director of Gnubiotics Sciences and Piqur Therapeutics SA. He has previously served as independent board member of Logitech SA. Mr Laube holds an MA and BA in Psychology from Boston University, US.

For more information : https://www.glanbia.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.